Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NTRA vs GSK✓SelectedUSD · GSKNTRA vs GSK performance historyLatest closeAs of+0.15%11/19
Stock and ETF performance explorer

NTRA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+181.0%
GSK return
+39.6%
Excess return
+141.4%
Maximum drawdown
-72.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-1.6%+1.7%+0.3%
7D-10.2%-4.7%-5.5%-9.7%
30D-28.6%-4.7%-23.9%-28.2%
3M-10.8%-8.8%-2.1%-9.8%
6M+47.9%-4.6%+52.5%+48.4%
YTD+26.6%+1.0%+25.6%+26.1%
1Y+32.8%+6.9%+25.9%+31.4%
3Y+441.7%+52.5%+389.2%+409.6%
5Y+181.0%+40.3%+140.7%+166.6%
All+181.0%+39.6%+141.4%+166.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling